Is the BCR-ABL/GUSB transcript level at diagnosis an early predictive marker for chronic myeloid leukemia patients treated with imatinib?

Detalles Bibliográficos
Autores principales: Bonecker, Simone, Magnago, Marina, Kaeda, Jaspal, Solza, Cristiana, Zalcberg Renault, Ilana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2015
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382567/
https://www.ncbi.nlm.nih.gov/pubmed/25818829
http://dx.doi.org/10.1016/j.bjhh.2014.08.003
_version_ 1782364601253363712
author Bonecker, Simone
Magnago, Marina
Kaeda, Jaspal
Solza, Cristiana
Zalcberg Renault, Ilana
author_facet Bonecker, Simone
Magnago, Marina
Kaeda, Jaspal
Solza, Cristiana
Zalcberg Renault, Ilana
author_sort Bonecker, Simone
collection PubMed
description
format Online
Article
Text
id pubmed-4382567
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Sociedade Brasileira de Hematologia e Hemoterapia
record_format MEDLINE/PubMed
spelling pubmed-43825672015-04-07 Is the BCR-ABL/GUSB transcript level at diagnosis an early predictive marker for chronic myeloid leukemia patients treated with imatinib? Bonecker, Simone Magnago, Marina Kaeda, Jaspal Solza, Cristiana Zalcberg Renault, Ilana Rev Bras Hematol Hemoter Letter to the Editor Sociedade Brasileira de Hematologia e Hemoterapia 2015 2015-01-31 /pmc/articles/PMC4382567/ /pubmed/25818829 http://dx.doi.org/10.1016/j.bjhh.2014.08.003 Text en © 2015 Associação Brasileira de Hematologia,Hemoterapia e Terapia Celular. Published by Elsevier EditoraLtda. All rights reserved. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Letter to the Editor
Bonecker, Simone
Magnago, Marina
Kaeda, Jaspal
Solza, Cristiana
Zalcberg Renault, Ilana
Is the BCR-ABL/GUSB transcript level at diagnosis an early predictive marker for chronic myeloid leukemia patients treated with imatinib?
title Is the BCR-ABL/GUSB transcript level at diagnosis an early predictive marker for chronic myeloid leukemia patients treated with imatinib?
title_full Is the BCR-ABL/GUSB transcript level at diagnosis an early predictive marker for chronic myeloid leukemia patients treated with imatinib?
title_fullStr Is the BCR-ABL/GUSB transcript level at diagnosis an early predictive marker for chronic myeloid leukemia patients treated with imatinib?
title_full_unstemmed Is the BCR-ABL/GUSB transcript level at diagnosis an early predictive marker for chronic myeloid leukemia patients treated with imatinib?
title_short Is the BCR-ABL/GUSB transcript level at diagnosis an early predictive marker for chronic myeloid leukemia patients treated with imatinib?
title_sort is the bcr-abl/gusb transcript level at diagnosis an early predictive marker for chronic myeloid leukemia patients treated with imatinib?
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382567/
https://www.ncbi.nlm.nih.gov/pubmed/25818829
http://dx.doi.org/10.1016/j.bjhh.2014.08.003
work_keys_str_mv AT boneckersimone isthebcrablgusbtranscriptlevelatdiagnosisanearlypredictivemarkerforchronicmyeloidleukemiapatientstreatedwithimatinib
AT magnagomarina isthebcrablgusbtranscriptlevelatdiagnosisanearlypredictivemarkerforchronicmyeloidleukemiapatientstreatedwithimatinib
AT kaedajaspal isthebcrablgusbtranscriptlevelatdiagnosisanearlypredictivemarkerforchronicmyeloidleukemiapatientstreatedwithimatinib
AT solzacristiana isthebcrablgusbtranscriptlevelatdiagnosisanearlypredictivemarkerforchronicmyeloidleukemiapatientstreatedwithimatinib
AT zalcbergrenaultilana isthebcrablgusbtranscriptlevelatdiagnosisanearlypredictivemarkerforchronicmyeloidleukemiapatientstreatedwithimatinib

Ejemplares similares